Sucralfate pharmacokinetics
Pro Research Analysisby 
Searched over 200M research papers for "sucralfate pharmacokinetics"
Sucralfate Pharmacokinetics: Absorption, Bioavailability, and Drug Interactions
Sucralfate Absorption and Systemic Exposure
Sucralfate itself is not significantly absorbed when taken orally, so it remains in the gastrointestinal tract and acts locally to form a protective barrier on the mucosa. Because of this, systemic exposure to sucralfate is minimal, and its pharmacokinetic effects are mostly related to its interactions with other orally administered drugs rather than its own absorption or metabolism .
Impact of Sucralfate on Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
When sucralfate is co-administered with NSAIDs such as ketoprofen, indomethacin, and naproxen, it can decrease the maximum plasma concentration (Cmax) and increase the time to reach this concentration (tmax), indicating a slower rate of absorption. However, the overall bioavailability (total amount absorbed) of these drugs is not significantly affected, meaning the total exposure to the drug remains the same even though absorption is delayed 134. This suggests that while sucralfate may slow the absorption of some NSAIDs, it does not reduce their effectiveness in terms of the total amount absorbed.
Sucralfate and Fluoroquinolone Antibiotics
Sucralfate can significantly reduce the absorption and bioavailability of certain fluoroquinolone antibiotics. For example, when norfloxacin or ofloxacin are taken with sucralfate, their bioavailability drops by 91% and 61%, respectively. This interaction can be minimized if the antibiotics are taken at least two hours before sucralfate . Ciprofloxacin bioavailability is also reduced by about 30% when sucralfate is given before it, with some individuals experiencing even greater reductions . Fleroxacin, another fluoroquinolone, shows a more modest reduction in bioavailability (to 76% of normal) when taken with sucralfate, which is less severe than with other drugs in this class . These findings highlight the importance of timing when administering fluoroquinolones with sucralfate to avoid reduced therapeutic effects 267.
Sucralfate and Other Drugs
For drugs like aspirin, sucralfate does not significantly alter pharmacokinetic parameters such as absorption, metabolism, or elimination. This means that the therapeutic effect of aspirin is not expected to change when taken with sucralfate . Reviews of drug interactions with sucralfate confirm that while it can reduce the bioavailability of some drugs, especially certain antibiotics, the impact on other drug classes is generally manageable and can often be addressed by adjusting dosing schedules .
Conclusion
Sucralfate is minimally absorbed and acts locally in the gut, but it can affect the absorption of other orally administered drugs. It slows the absorption of some NSAIDs without reducing their total bioavailability, but it can significantly reduce the absorption of certain fluoroquinolone antibiotics unless dosing is carefully managed. For most other drugs, including aspirin, sucralfate does not cause clinically significant pharmacokinetic interactions. Proper timing of drug administration can help avoid most clinically relevant interactions with sucralfate.
Sources and full results
Most relevant research papers on this topic